missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30028610

Peroxiredoxin 4 Antibody (OTI9A3), Allophycocyanin, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-73338APC

Product Code. 30028610

  • € 740.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Peroxiredoxin 4 Monoclonal antibody specifically detects Peroxiredoxin 4 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Peroxiredoxin 4
Monoclonal
APC
PBS
Mouse
Immunogen affinity purified
RUO
Primary
Human, Mouse, Rat
Purified
Western Blot, Immunohistochemistry, Immunocytochemistry
OTI9A3
Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence
Antioxidant enzyme AOE372, AOE37-2PRX-4, EC 1.11.1.15, peroxiredoxin 4, Peroxiredoxin IV, peroxiredoxin-4, prx4, prx-4, Prx-IV, thioredoxin peroxidase (antioxidant enzyme), Thioredoxin peroxidase AO372, Thioredoxin-dependent peroxide reductase A0372
Full length human recombinant protein of human PRDX4 (NP_006397) produced in HEK293T cell.
0.1 mL
Signal Transduction
10549
Store at 4C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.